Technology area: Biotechnology & Pharmaceuticals
13 pending office actions • 9 clients • 11 examiners • 11 art units • 0 of 13 (0%) have an AI response strategy ready
KRAMER & AMADO, P.C. prosecutes Biotechnology & Pharmaceuticals matters and has 873 career applications. The firm currently has 13 pending office actions, reflecting continuing activity in the listed technology area.
The resolved allowance rate is 80.86%. Allowed matters required an average of 3.84 office actions, indicating that successful cases generally involved several rounds of examination interaction. Practitioners can consider these figures when assessing outcome history and the effort likely to be required during prosecution.
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 5 (38%) |
| §102 only | 1 (8%) |
| §112 only | 1 (8%) |
| Multi-statute (no §101) | 6 (46%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUNTER, MISHAWN N | 2 | 78.3% | +14.3% |
| MACFARLANE, STACEY NEE | 2 | 53.7% | +39.5% |
| VALLE, ERNESTO | 1 | 65.8% | +32.9% |
| BAZARGANI, ARYA AHMADI | 1 | 62.5% | +31.3% |
| PEEBLES, KATHERINE | 1 | 35.6% | +48.0% |
| GONZALEZ, LUISALBERTO | 1 | 59.7% | +46.3% |
| BOECKELMAN, JACOB A | 1 | 34.9% | +46.5% |
| ADDIE, RAYMOND W | 1 | 81.1% | +8.6% |
| WRIGHT, PATRICIA KATHRYN | 1 | 65.3% | +42.6% |
| MARCHESCHI, MICHAEL A | 1 | 20.0% | +17.9% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17507961 | ROAD PLATE MOVING SYSTEM AND METHOD | ADDIE, RAYMOND W | 15d overdue |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18054285 | Compositions Comprising Human Skin Fibroblasts and Amyloid Beta Peptide | MACFARLANE, STACEY NEE | 70d overdue |
| 19456751 | INTERACTIVE SAFETY SYSTEM FOR VEHICLES | HUNTER, MISHAWN N | — |
| 18547044 | NON-AQUEOUS INJECTABLE COMPOSITION OR SUSTAINED RELEASE OF BUPRENORPHINE AND USE THEREOF | BAZARGANI, ARYA AHMADI | — |
| 18547025 | AN EFLORNITHINE COMPOSITION FOR INHIBITING HAIR GROWTH | PEEBLES, KATHERINE | — |
| 18256295 | BIO PESTICIDAL COMPOSITION CONTAINS NOVEL NONANOATE ESTERS OF SUGARS AND SUGAR ALCOHOLS TO CONTROL LEPIDOPTERA, HEMIPTERA AND THYSANOPTERA INSECTS | GONZALEZ, LUISALBERTO | — |
| 17048485 | CELL SEPARATION CHAMBER AND CELL SEPARATION SYSTEM AND METHOD | MARCHESCHI, MICHAEL A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17066961 | FIBROBLAST GROWTH PATTERNS FOR DIAGNOSIS OF ALZHEIMER'S DISEASE | MACFARLANE, STACEY NEE | 74d overdue |
| 18054285 | Compositions Comprising Human Skin Fibroblasts and Amyloid Beta Peptide | MACFARLANE, STACEY NEE | 70d overdue |
| 17554636 | COMPOSITION FOR ENHANCEMENT OF BIOAVAILABILITY OF PHYTOCHEMICALS AND PROCESS FOR PREPARATION THEREOF | BOECKELMAN, JACOB A | 5d overdue |
| 19456751 | INTERACTIVE SAFETY SYSTEM FOR VEHICLES | HUNTER, MISHAWN N | — |
| 18820892 | Interactive Safety System for Vehicles | HUNTER, MISHAWN N | — |
| 18548691 | SOLID STATE FORMS OF 2-(3,5-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND POLYMORPHS THEREOF | VALLE, ERNESTO | — |
| 18547044 | NON-AQUEOUS INJECTABLE COMPOSITION OR SUSTAINED RELEASE OF BUPRENORPHINE AND USE THEREOF | BAZARGANI, ARYA AHMADI | — |
| 18547025 | AN EFLORNITHINE COMPOSITION FOR INHIBITING HAIR GROWTH | PEEBLES, KATHERINE | — |
| Art Unit | Apps |
|---|---|
| 2484 | 2 |
| 1675 | 2 |
| 1623 | 1 |
| 1613 | 1 |
| 1617 | 1 |
| 1624 | 1 |
| 1655 | 1 |
| 3671 | 1 |
| 1798 | 1 |
| 1796 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19456751 | INTERACTIVE SAFETY SYSTEM FOR VEHICLES | Libre Holdings Inc. | HUNTER, MISHAWN N | 2484 | §102§103§112 | Non-Final OA | — | Pending | Jan 22, 2026 |
| 18820892 | Interactive Safety System for Vehicles | Libre Holdings, Inc. | HUNTER, MISHAWN N | 2484 | §103 | Final Rejection | — | Pending | Aug 30, 2024 |
| 18548691 | SOLID STATE FORMS OF 2-(3,5-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND POLYMORPHS THEREOF | Cipla Limited | VALLE, ERNESTO | 1623 | §112 | Final Rejection | — | Pending | Sep 01, 2023 |
| 18547044 | NON-AQUEOUS INJECTABLE COMPOSITION OR SUSTAINED RELEASE OF BUPRENORPHINE AND USE THEREOF | Navin Saxena Research And Technology Private Limited | BAZARGANI, ARYA AHMADI | 1613 | §103§112 | Final Rejection | — | Pending | Aug 18, 2023 |
| 18547025 | AN EFLORNITHINE COMPOSITION FOR INHIBITING HAIR GROWTH | Navin Saxena Research And Technology Private Limited | PEEBLES, KATHERINE | 1617 | §103§112 | Non-Final OA | — | Pending | Aug 18, 2023 |
| 18256295 | BIO PESTICIDAL COMPOSITION CONTAINS NOVEL NONANOATE ESTERS OF SUGARS AND SUGAR ALCOHOLS TO CONTROL LEPIDOPTERA, HEMIPTERA AND THYSANOPTERA INSECTS | Fertis India Pvt. Ltd. | GONZALEZ, LUISALBERTO | 1624 | §103§112 | Non-Final OA | — | Pending | Jun 07, 2023 |
| 18054285 | Compositions Comprising Human Skin Fibroblasts and Amyloid Beta Peptide | West Virginia University | MACFARLANE, STACEY NEE | 1675 | §102§103 | Final Rejection | 70d overdue | Pending | Nov 10, 2022 |
| 17554636 | COMPOSITION FOR ENHANCEMENT OF BIOAVAILABILITY OF PHYTOCHEMICALS AND PROCESS FOR PREPARATION THEREOF | Olene Life Sciences Private Limited | BOECKELMAN, JACOB A | 1655 | §103 | Non-Final OA | 5d overdue | Pending | Dec 17, 2021 |
| 17507961 | ROAD PLATE MOVING SYSTEM AND METHOD | Fer-Pal Construction, Ltd. | ADDIE, RAYMOND W | 3671 | §103 | Non-Final OA | 15d overdue | Pending | Oct 22, 2021 |
| 17048766 | DISPOSABLE CARTRIDGE COOPERATING WITH A PLATFORM IN A FLEXIBLE SYSTEM FOR HANDLING AND/OR MANIPULATING FLUIDS | Aglaris Ltd. | WRIGHT, PATRICIA KATHRYN | 1798 | §103 | Final Rejection | — | Pending | Oct 19, 2020 |
| 17048485 | CELL SEPARATION CHAMBER AND CELL SEPARATION SYSTEM AND METHOD | Aglaris Ltd. | MARCHESCHI, MICHAEL A | 1796 | §103§112 | Final Rejection | — | Pending | Oct 16, 2020 |
| 17066961 | FIBROBLAST GROWTH PATTERNS FOR DIAGNOSIS OF ALZHEIMER'S DISEASE | West Virginia University | MACFARLANE, STACEY NEE | 1675 | §103 | Final Rejection | 74d overdue | Pending | Oct 09, 2020 |
| 15107152 | CONVERGENCE OF AGGREGATION RATE WITH VALIDATED PERIPHERAL DIAGNOSTIC FOR ALZHEIMER'S DISEASE | West Virginia University | NGUYEN, NGHI V | 1653 | §102 | Final Rejection | 69d | Pending | Jun 22, 2016 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial80.9% of resolved applications prosecuted by Kramer & Amado, P.C. were allowed, across 873 applications in USPTO records.
3.84 office actions per allowed application on average.
13 pending office actions as of October 2026, for 9 clients, before 11 examiners in 11 art units.
